Showing recent highlights
What's New
PubMed · December 31, 2026
Researchers looked at a group of studies and found that low sodium levels in the blood — a condition called hyponatremia, where the body doesn't have enough of this important mineral — appear to be surprisingly common in people with COPD (a serious lung disease that makes breathing difficult). About 1 in 5 people with a sudden COPD flare-up may have this issue, which is worth paying attention to because low sodium can affect how the body functions overall. Interestingly, most of the studies didn't find a clear link between low sodium and a higher risk of death from a COPD flare-up, but scientists say the results varied too much between studies to draw firm conclusions. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers in China tested whether a low dose of an older medicine called theophylline — which can reduce inflammation in the airways — might help people with mild to moderate COPD, a lung disease that makes breathing harder over time. They found a small improvement in lung function (how much air people could blow out), but the medicine did not reduce the number of times patients had flare-ups, which are sudden worsening spells that can be dangerous. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
A study found that in ex-smokers — both those with COPD and those considered at risk for it — mucus plugs in the airways kept forming and shifting over time, even when overall mucus levels stayed roughly the same. More importantly, these participants also showed a gradual decline in how far they could walk and how well air moved through their lungs, suggesting that mucus buildup may be quietly contributing to worsening lung health even in earlier or milder stages of the disease. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that people with COPD — a lung condition that makes it hard to breathe — face a mix of real-world challenges when trying to manage their condition day to day. Things like rushed doctor appointments, feelings of shame or emotional distress, and not getting enough clear information from healthcare professionals made it harder for people to stick to their treatment plans, while having strong support from family and friends and feeling genuinely heard by their care team made a big difference. Understanding what gets in the way — and what helps — could lead to better, more personalized support for people living with COPD. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that certain biologic medications — injectable drugs that target specific parts of the immune system to reduce inflammation — may help people with moderate-to-severe COPD (a serious lung disease that makes breathing difficult) have fewer flare-ups, which are episodes when symptoms suddenly get much worse. Specifically, they found that for every 12 to 17 people treated with a biologic called dupilumab, roughly one person avoided a flare-up they otherwise would have had — and when looking at the total number of flare-ups prevented, the benefit appeared even stronger. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that digital tools designed to help people with COPD (a lung disease that makes breathing difficult) manage their condition on their own — things like apps, online programs, or remote monitoring — were linked to improvements in physical activity, quality of life, lung function, medication adherence, and mental health challenges like anxiety and depression. This matters because COPD can be isolating and hard to manage day-to-day, and digital tools could make support more accessible to more people. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that applying elastic tape — a stretchy, supportive tape placed on the chest — alongside a standard breathing and exercise program helped men with moderate-to-severe COPD walk longer, breathe more comfortably, and feel less anxious or depressed compared to those who did the program without the tape. COPD is a lung disease that makes it hard to breathe, and finding ways to get more out of exercise programs matters a lot for people living with it. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that a structured self-management program — where people with chronic conditions like type 2 diabetes learn skills to manage their health day-to-day — led to lasting improvements in sleep, pain, fatigue, and mood, even six months after the program ended, across many different countries. For someone with type 2 diabetes, this matters because managing a long-term condition involves a lot more than just medication — things like energy levels, sleep, and emotional well-being all affect how well someone can stay on top of their health. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed · September 1, 2026
The text describes a systematic review — a study that gathered and compared existing guidelines — but does not clearly name a specific medical society or authoritative body issuing the recommendations, so it cannot be presented as a single organization's guidance. The review found that most guidelines for people with COPD (a lung disease that makes breathing difficult) consistently recommended at least 150 minutes of moderate physical activity per week, such as brisk walking or cycling, though detailed, condition-specific advice was often limited.
What's New
PubMed · September 1, 2026
Researchers found that a traditional Chinese herbal medicine called Qibai Pingfei Capsule may help people with COPD — a lung disease that makes it hard to breathe — by reducing how often their symptoms suddenly get much worse (called flare-ups) and improving how they feel day-to-day. The study also found that COPD affects certain immune cells called NK cells, which normally help the body fight off threats, and that this herbal treatment appeared to help restore some of that immune activity. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that people with COPD (a lung disease that makes breathing difficult) who did eight weeks of intense breathing muscle exercises — taking 30 strong, effortful breaths twice a day — showed meaningful improvements in how their heart and nervous system work together, including a calmer stress response and more stable blood pressure patterns. This matters because people with COPD often have heart-related complications alongside their breathing problems, so finding a simple exercise that may help both systems at once is encouraging. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that for people with COPD (a chronic lung disease that makes it hard to breathe), reaching a state of 'disease stability' — meaning no flare-ups and no worsening of symptoms or lung function — was linked to significantly better outcomes. Patients who achieved this stable state were much less likely to experience serious flare-ups or die in the months that followed, compared to those who didn't reach stability. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that a medication called mepolizumab helped reduce flare-ups in people with COPD (a lung disease that makes breathing difficult) who had higher levels of a specific immune cell called eosinophils in their blood — think of these as a marker that certain airway inflammation is present. Even people whose eosinophil levels bounced around over time still saw fewer serious flare-ups, including ones that sent them to the emergency room or hospital, with reductions ranging from about 12% to 36% depending on the group. People with consistently low eosinophil levels, however, did not appear to benefit from this medication. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that traces of a COPD inhaler medication called formoterol can be detected in hair samples, and the levels in hair loosely matched how often patients actually used their inhaler — as tracked by a digital device on the inhaler itself. This is interesting because many people with COPD don't take their inhaler as often as prescribed, and a simple hair test could one day give doctors a clearer, longer-term picture of how consistently someone has been using their medication over the past few months. This is early research and hasn't yet changed treatment guidelines.
Medications
PubMed · September 1, 2026
Researchers found that dupilumab (brand name Dupixent), a medication given by injection, helped people with COPD — a serious lung disease that makes breathing difficult — in two important ways: it reduced emergency room visits and hospital stays by 38%, and it lowered the need for steroid pills or shots (which are commonly used during flare-ups but can cause problems with long-term use) by up to 42%. This appears to be a new and emerging option for a specific group of COPD patients whose condition involves a certain type of airway inflammation, though anyone interested should speak with their doctor about whether it might be relevant to their situation.
Ask your doctor: Ask the doctor whether dupilumab might help reduce the patient's emergency room visits and hospital stays if the patient has COPD with type 2 inflammation.
Medications
PubMed · September 1, 2026
Researchers found that a medication called astegolimab helped people with COPD — a serious lung disease that makes breathing difficult — who had frequent flare-ups, meaning episodes when their symptoms suddenly got much worse. The study showed that astegolimab reduced these flare-ups by around 12–15%, with the most severe flare-ups dropping by about 32% compared to people who received a placebo (a dummy treatment with no active medicine). This appears to be a new potential option being studied for people with COPD who struggle with frequent flare-ups, though it is not yet an established treatment.
Ask your doctor: Ask the doctor whether astegolimab might help reduce how often the patient has flare-ups of COPD symptoms, based on what the patient's doctor knows about the patient's condition.
What's New
PubMed · September 1, 2026
Researchers found that people with COPD (a lung disease that makes breathing difficult) who received one-on-one coaching sessions during their breathing rehabilitation program walked more steps, spent less time sitting still, and felt more motivated to exercise compared to those who did rehabilitation alone — all after just three months. This matters because staying active is especially challenging for people with COPD, and even small increases in daily movement can help support lung health and overall wellbeing. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that for people with COPD who have serious breathing problems and need a breathing support machine at home (called non-invasive ventilation), there is no single agreed-upon way to set up or manage that care — and approaches vary widely around the world. The review highlighted that regular check-ins every 3 to 6 months, good patient education, and remote monitoring tools (where a care team can track the machine's data from a distance) all seem to help people stick with treatment and do better. This matters because having a clear, consistent plan for home breathing support could make a real difference in quality of life for people living with advanced COPD. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 24, 2026
Researchers found that giving people with COPD — a lung disease that makes breathing difficult — real-time visual feedback of how air moves through their lungs while using their inhaler may help them breathe more effectively. Specifically, people who received this feedback showed a notable reduction in 'air trapping,' which is when stale air gets stuck in the lungs and makes it harder to take a full breath — a common and uncomfortable problem in COPD. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 21, 2026
Researchers found — or rather, are currently investigating — whether tracking vital signs from home using a smartphone app can help people with COPD who depend on oxygen therapy every day. The idea is that staying connected to their care team through daily readings like heart rate and oxygen levels, without having to leave home, might improve their quality of life and ease feelings of breathlessness, anxiety, or depression. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that using a quick fingerstick-style blood test — done right in the doctor's office — to measure a marker of inflammation called CRP (C-reactive protein) could significantly cut down on unnecessary antibiotic prescriptions for people having a COPD flare-up. This matters because taking antibiotics when they aren't needed can lead to antibiotic resistance, meaning the drugs may stop working when they're truly needed, and the medications themselves can cause unwanted side effects. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that short bursts of intense exercise — called high-intensity interval training, where you push hard for a bit, then rest and repeat — helped people with COPD (a lung condition that makes breathing difficult) more than steady, moderate exercise done at a continuous pace. Across 16 studies, people who did this type of interval exercise showed better walking ability, greater fitness levels, and improved quality of life, with no serious injuries or health scares linked to the training. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed · August 1, 2026
According to the Asian Society of Thoracic Radiology guidelines, doctors evaluating patients with COPD — a lung disease that makes it hard to breathe — should use chest CT scans (detailed X-ray images of the lungs) in a more standardized, consistent way across Asia, because standard breathing tests alone can miss the disease early or fail to capture how differently it shows up from person to person. The guidelines recommend using low-dose CT scans taken at two different points during breathing, along with structured reporting and newer tools like artificial intelligence, to help doctors spot COPD sooner and track how it's progressing in each individual patient. This matters because catching and understanding COPD earlier can lead to more personalized care and potentially reduce the serious health and financial burden the disease places on patients and communities.
What's New
PubMed · August 1, 2026
Researchers found that people with COPD (a lung disease that makes breathing difficult) who also have sleep problems tend to have a harder time with physical activities — like walking tests and daily movement — compared to those without sleep issues. The connection was real but not dramatically strong, meaning sleep troubles appear to be one piece of a larger puzzle affecting how well people with COPD can get around and stay active. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that neither a fentanyl skin patch nor morphine pills did a better job than a placebo (a dummy treatment with no active ingredient) at relieving the constant, distressing shortness of breath that many people with advanced COPD experience every day. This matters because shortness of breath is one of the most difficult parts of living with serious COPD, and doctors have hoped opioid-based medicines might help — but this study adds to growing doubts about whether they actually do. This is early research and hasn't yet changed treatment guidelines.
Watch Out For
FDA MedWatch · July 31, 2026
Be aware that certain ResMed Astral ventilators — breathing machines that help people breathe — may have a faulty electrical part that could cause the device to suddenly stop working. If a ventilator stops delivering air or behaves unexpectedly, this is a serious situation that could lead to harm. Anyone using one of these devices should contact their doctor or care team right away if they notice any changes in how their machine is functioning.
Ask your doctor: Ask the doctor whether the patient's ResMed Astral ventilator is included in the recent safety alert about a faulty electrical component that could stop it from working.
What's New
PubMed · July 24, 2026
Researchers found that very few people with COPD — a lung disease that makes breathing difficult — ever take part in pulmonary rehabilitation, which is a structured program of exercise and education designed to help them breathe better and stay active, and even fewer finish it. To help bridge that gap, a study is testing whether a smartphone app can help people with COPD stay motivated and keep moving on their own after their in-person program ends. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 17, 2026
Researchers found that people with COPD (a lung disease that makes breathing difficult) face a mix of personal and social challenges that affect how active they stay in daily life — things like managing symptoms and low mood, but also what helps them keep moving, such as support from family, friends, and healthcare providers. Even after completing breathing rehabilitation programs, many people tend to slip back into sitting still most of the day, and this review looked at why that happens and what makes a difference. Understanding these real-life experiences could help create better, more personal support plans for people living with COPD. This is early research and hasn't yet changed treatment guidelines.
Watch Out For
FDA MedWatch · July 15, 2026
Be aware that certain ResMed Astral breathing machines (ventilators) may have a faulty electrical part that could cause the device to stop working unexpectedly, which could be very dangerous or even life-threatening for people who depend on it to breathe. If someone uses one of these machines, they or their caregiver should watch for any signs that the device is not working as expected, such as unusual alarms, the machine shutting off, or the person having trouble breathing. Anyone using this device should contact their doctor or equipment provider right away to find out if their specific machine is affected.
Ask your doctor: Ask the doctor whether the patient's Resmed Astral ventilator is one of the models with the electrical component problem that was recently reported, and what the patient should do about it.
Watch Out For
FDA MedWatch · July 14, 2026
Be aware that certain Volera breathing devices (made by Baxter) may have a problem where air and medication leak out during use, which could mean patients aren't getting enough oxygen or their full dose of inhaled medication. People using this device should watch for any signs that their breathing treatment doesn't seem to be working as well as usual, or if they feel short of breath or unwell during or after a session. Anyone with concerns about their device or how they're feeling during treatment should reach out to their doctor or care team right away.
Ask your doctor: Ask the doctor whether the patient's Volara positive pressure breathing device has been checked for air leaks that could reduce how much oxygen the patient is getting during treatment.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.